FACL5 Inhibitors
The FACL5 gene, a critical part of cellular lipid metabolism, is central to the intricate web of biochemical pathways responsible for the synthesis and breakdown of fatty acids within the cell. The expression of FACL5 is an essential process, tightly controlled and responsive to a myriad of intracellular and extracellular signals, ensuring that the balance of lipid synthesis and degradation is maintained in accordance with the cell's metabolic demands. FACL5 plays a pivotal role in the complex orchestration of lipid-related functions, and its activity is subject to sophisticated regulation by various molecular mechanisms. This regulation is not only fundamental to normal cellular function but may also be influenced by certain chemical compounds capable of modulating gene expression at multiple levels, from transcription to translation and post-translational modifications.
A diverse array of chemical compounds has been identified with the potential to inhibit the expression of the FACL5 gene, each intervening through a unique mechanism of action. For instance, compounds like 5-Azacytidine act by demethylating DNA at specific gene loci, which can lead to a downregulation of gene expression through transcriptional repression. Histone deacetylase inhibitors, such as Trichostatin A, may induce hyperacetylation of histones, resulting in a less accessible chromatin structure and consequently a decrease in gene transcription. Other compounds, such as Wortmannin and Rapamycin, function by disrupting key signaling pathways, like PI3K/Akt and mTOR respectively, which are often involved in the regulation of gene expression, including that of FACL5. Additionally, dietary components like Sulforaphane and Omega-3 fatty acids have been found to modulate gene expression, potentially affecting FACL5 by altering the activity of transcription factors and associated signaling pathways. These compounds, through their varied interactions with cellular processes, elucidate the complexity of gene regulation and highlight the intricate nature of controlling gene expression within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could demethylate the DNA within the promoter region of the FACL5 gene, leading to a decrease in gene expression as promoter demethylation often results in transcriptional repression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a specific inhibitor of histone deacetylases, Trichostatin A may lead to hyperacetylation of histones near the FACL5 gene, resulting in a tightly packed chromatin structure and decreased accessibility for transcription machinery, thus downregulating FACL5 expression. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $124.00 $502.00 | 13 | |
Garcinol may directly inhibit the activity of histone acetyltransferases associated with the FACL5 gene, leading to hypoacetylation of histones, which usually correlates with reduced transcriptional activity, potentially diminishing FACL5 mRNA levels. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
By inhibiting PI3K, Wortmannin could disrupt downstream signaling pathways including Akt, which may play a role in the expression of genes like FACL5, resulting in its reduced transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An inhibitor of the mTOR pathway, Rapamycin could suppress the initiation of translation for various mRNAs, including potentially those transcribed from the FACL5 gene, thereby decreasing FACL5 protein synthesis. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane can inhibit the activation of the NF-κB pathway, which might be responsible for the transcriptional activation of certain genes including FACL5, leading to a decrease in FACL5 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As an inhibitor of MEK1/2, PD 98059 could disrupt the MAPK/ERK signaling cascade, which may be necessary for the upregulation of FACL5 expression under certain conditions, thus leading to a downregulation of the gene. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog acts as a competitive inhibitor of glycolysis, which can induce a cellular starvation-like response, potentially leading to the downregulation of metabolic genes such as FACL5. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, by activating retinoic acid receptors, can change the transcriptional program of a cell, which may include downregulating genes like FACL5 if they are part of the cellular response to retinoid signaling. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to have a suppressive effect on the transcriptional activity of various genes by altering the activity of specific transcription factors, which could result in decreased expression of FACL5. | ||||||